Ara Hovanessian
19Patents
5h-index
23Co-inventors
66Inventor score
Filing activity: Aug 10, 1978 → Jun 26, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4210746A | Nucleotide inhibitor of protein synthesis | Chemistry; Metallurgy | 22 | Expired |
| US5208321A | HIV-2 transmembrane glycoprotein homodimer (GP 80) | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5312902A | Dimer of the precursor of HIV-2 envelope glycoprotein | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5807992A | HIV-2 transmembrane glycoprotein homodimer (gp 80) | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5470702A | HIV-2 transmembrane glycoprotein homodimer (gp 80) | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5756477A | Treatment of aids with complex of poly (A). poly (U) | Human Necessities | 5 | Expired |
| US6056963A | Immunogenic compositions comprising glycosylated and deglycosylated monomeric and dimeric forms of HIV-2 enveloped glycoproteins | Chemistry; Metallurgy | 3 | Expired |
| US6608179B1 | Antibodies, that bind to HIV-2 transmembrane glycoprotein homodimer (gp 80) | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6261571A | Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteins | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7507417B2 | Immunogenic compositions comprising human immunodeficiency virus type 2 (HIV-2) glycosylated and unglycosylated envelope proteins and their methods of preparation | Chemistry; Metallurgy | 2 | Active |
| US6984721B2 | Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80 | Chemistry; Metallurgy | 2 | Expired |
| US6197496A | Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80 | Chemistry; Metallurgy | 2 | Expired |
| US8497349B2 | Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation | Human Necessities | 2 | Active |
| US7364744B2 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | Chemistry; Metallurgy | 1 | Expired |
| US8173767B2 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | Chemistry; Metallurgy | 1 | Active |
| US9254309B2 | Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation | Human Necessities | 0 | Active |
| US5736525A | Complexes of polyadenylic acid with polyuridylic acid | Human Necessities | 0 | Expired |
| US8790898B2 | Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies | Chemistry; Metallurgy | 0 | Active |
| US9243030B2 | Optically pure compounds for improved therapeutic efficiency | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.